Emergency department screening and outpatient follow-up for new diabetes
Identifying Risk Factors for Poor Glycemic Control Among Emergency Department Patients and Improving Linkage to Outpatient Care
NA · NYU Langone Health · NCT05899023
This project will test whether telehealth bridge visits help emergency department patients newly diagnosed with diabetes (HbA1c ≥ 6.5%) connect to outpatient primary care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 20 Years to 70 Years |
| Sex | All |
| Sponsor | NYU Langone Health (other) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05899023 on ClinicalTrials.gov |
What this trial studies
This NIH-funded R01 at NYU Langone combines retrospective chart review, qualitative interviews, and a randomized controlled trial to improve follow-up after a new diabetes diagnosis in the ED. First, investigators will analyze past ED records to identify factors linked to failure to obtain outpatient care. Second, they will conduct interviews with patients who did not follow up to understand barriers to care. Finally, they will randomize eligible patients to a telehealth bridge visit versus standard care to measure whether telehealth improves linkage to primary care.
Who should consider this trial
Good fit: Ideal candidates are ED patients with an initial HbA1c ≥ 6.5% who are newly diagnosed, live in New York City or Long Island, speak English or Spanish, and can provide informed consent.
Not a fit: Patients who already have established diabetes care, live outside the study area, cannot use telehealth, or have medical conditions that make HbA1c unreliable (e.g., sickle cell disease, recent significant blood loss) are unlikely to benefit.
Why it matters
Potential benefit: If successful, the intervention could increase timely linkage to outpatient care, accelerate treatment initiation, and reduce early complications from uncontrolled diabetes.
How similar studies have performed: Previous research supports telehealth for improving outpatient follow-up and care coordination in other settings, but randomized trials specifically linking ED-diagnosed diabetes patients to primary care are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5% * Residential address in New York City or Long Island * Primary language is English or Spanish * Able to provide informed consent Exclusion Criteria: * No prior history of diabetes * No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: David C. Lee — NYU Langone Health
- Study coordinator: David C. Lee
- Email: David.Lee@nyulangone.org
- Phone: 212-562-6561
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus, Non Insulin Dependent Diabetes Mellitus